Bradley T. Hyman, MD PhD

Neurology Massachusetts General Hospital and Harvard University, Boston, MA, United States 
neuropathophysiologic and genetic factors that underlie dementia.
"Bradley T. Hyman"

Cross-listing: Neurotree - Neuropathology Tree


Sign in to add mentor
Arthur A. Specter grad student 1982 University of Iowa (Chemistry Tree)
 (Polyunsaturated fatty acid effects in neural tissue)
Antonio Damasio post-doc University of Iowa (Neurotree)
Gary Van Hoesen post-doc University of Iowa (Neurotree)


Sign in to add trainee
Kathryn K. Bercury research assistant 2005-2007 Massachusetts General Hospital and Harvard University (Neurotree)
Molly J. Kirk research assistant 2013-2015 Harvard Medical School (Neurotree)
Tadafumi Hashimoto post-doc (Neurotree)
Derek H. Oakley post-doc (Neurotree)
Manuela Polydoro post-doc MGH-Harvard
G. William Rebeck post-doc Massachusetts General Hospital & Harvard University
Hwan-Ching Bruce Tai post-doc MGH (Neurotree)
Shao-Qing Zhang post-doc Massachusetts General Hospital & Harvard Medical School (Chemistry Tree)
Vivek K. Unni post-doc 2007- Harvard (Neurotree)
Kelly A. Krogh post-doc 2015- Massachusetts General Hospital and Harvard University (Neurotree)
Prasenjit Mondal post-doc 2019- (Chemistry Tree)
Tara L. Spires-Jones post-doc 2004-2006 MGH (Neurotree)
Nikolaus R. McFarland post-doc 2006-2010 Massachusetts General Hospital & Harvard Medical School (Neurotree)
Pamela J. McLean post-doc 1997-2012 MGH (Neurotree)
Alberto Serrano-Pozo post-doc 2008-2013 Harvard Medical School - Massachusetts General Hospital (Neurotree)
Sarah Christine Hopp post-doc 2014-2018 (Neurotree)
Brian J. Bacskai research scientist MGH
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dujardin S, Commins C, Lathuiliere A, et al. (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nature Medicine
Huh YE, Ruby Chiang MS, Locascio JJ, et al. (2020) β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters. Neurology
Cable J, Holtzman DM, Hyman BT, et al. (2020) Alternatives to amyloid for Alzheimer's disease therapies-a symposium report. Annals of the New York Academy of Sciences
Oakley DH, Chung M, Klickstein N, et al. (2020) The Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble Aβ43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue. Journal of Neuropathology and Experimental Neurology
Rauch JN, Luna G, Guzman E, et al. (2020) LRP1 is a master regulator of tau uptake and spread. Nature. 580: 381-385
Sanderson JB, De S, Jiang H, et al. (2020) Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Communications. 2: fcaa010
Bakshi R, Macklin EA, Hung AY, et al. (2020) Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. Journal of Parkinson's Disease. 10: 505-510
Wilkins JM, Locascio JJ, Gunther JM, et al. (2020) Differences in Assessment of Everyday Preferences Between People With Cognitive Impairment and Their Care Partners: The Role of Neuropsychiatric Symptoms. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, et al. (2020) Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nature Communications. 11: 667
Lau A, So RWL, Lau HHC, et al. (2019) α-Synuclein strains target distinct brain regions and cell types. Nature Neuroscience
See more...